Free fatty acid receptor 2, a candidate target for type 1 diabetes, induces cell apoptosis through ERK signaling.

Recent reports have highlighted the roles of free fatty acid receptor 2 (FFAR2) in the regulation of metabolic and inflammatory processes. However, the potential function of FFAR2 in type 1 diabetes (T1D) remains unexplored. Our results indicated that the mRNA level of FFAR2 was upregulated in peripheral blood mononuclear cells of T1D patients. The human FFAR2 promoter regions were cloned, and luciferase reporter assays revealed that NFκB activation induced FFAR2 expression. Furthermore, we showed that FFAR2 activation by overexpression induced cell apoptosis through ERK signaling. Finally, treatment with the FFAR2 agonists acetate or phenylacetamide 1 attenuated the inflammatory response in multiple-low-dose streptozocin-induced diabetic mice, and improved the impaired glucose tolerance. These results indicate that FFAR2 may play a protective role by inducing apoptosis of infiltrated macrophage in the pancreas through its feedback upregulation and activation, thus, in turn, improving glucose homeostasis in diabetic mice. These findings highlight FFAR2 as a potential therapeutic target of T1D, representing a link between immune response and glucose homeostasis.

[1]  T. Schwartz,et al.  GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. , 2013, Endocrinology.

[2]  G. Tsujimoto,et al.  The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43 , 2013, Nature Communications.

[3]  N. Delzenne,et al.  GPR43/FFA2: physiopathological relevance and therapeutic prospects. , 2013, Trends in pharmacological sciences.

[4]  W. Lowe,et al.  Short chain fatty acids and their receptors: new metabolic targets. , 2013, Translational research : the journal of laboratory and clinical medicine.

[5]  O. Feron,et al.  Gut microbiota-derived propionate reduces cancer cell proliferation in the liver , 2012, British Journal of Cancer.

[6]  B. Boehm,et al.  Anti-Inflammatory Therapy in Type 1 Diabetes , 2012, Current Diabetes Reports.

[7]  L. Heinemann,et al.  Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial) , 2012, PloS one.

[8]  Weiqing Wang,et al.  Acute Response of Peripheral Blood Cell to Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetic Patient , 2012, PloS one.

[9]  A. M. Habib,et al.  Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2 , 2012, Diabetes.

[10]  M. Atkinson,et al.  Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients , 2012, The Journal of experimental medicine.

[11]  H. Snieder,et al.  Glycotoxin and Autoantibodies Are Additive Environmentally Determined Predictors of Type 1 Diabetes , 2011, Diabetes.

[12]  P. Hawkins,et al.  SCFAs Induce Mouse Neutrophil Chemotaxis through the GPR43 Receptor , 2011, PloS one.

[13]  D. Nie,et al.  Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death , 2011, Cell Death and Differentiation.

[14]  K. Massey,et al.  High Pancreatic n-3 Fatty Acids Prevent STZ-Induced Diabetes in Fat-1 Mice: Inflammatory Pathway Inhibition , 2011, Diabetes.

[15]  D. Nie,et al.  G‐protein‐coupled receptor for short‐chain fatty acids suppresses colon cancer , 2011, International journal of cancer.

[16]  I. Kaji,et al.  Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide , 2011, Journal of Molecular Histology.

[17]  G. Ning,et al.  Andrographolide attenuates tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes , 2011, Molecular and Cellular Endocrinology.

[18]  A. Cooke,et al.  Immune cell crosstalk in type 1 diabetes , 2010, Nature Reviews Immunology.

[19]  M. Cawthorne,et al.  Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids , 2010, FEBS letters.

[20]  M. Donath,et al.  Blockade of interleukin 1 in type 1 diabetes mellitus , 2010, Nature Reviews Endocrinology.

[21]  R. Xavier,et al.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.

[22]  Yang Li,et al.  Identification and Functional Characterization of Allosteric Agonists for the G Protein-Coupled Receptor FFA2 , 2008, Molecular Pharmacology.

[23]  Masashi Yanagisawa,et al.  Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41 , 2008, Proceedings of the National Academy of Sciences.

[24]  Yang Li,et al.  Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. , 2008, Endocrinology.

[25]  宇野 彩.  Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-α in patients with recent-onset type 1 diabetes , 2007 .

[26]  A. Strasser,et al.  The BH3-Only Protein Bid Is Dispensable for DNA Damage- and Replicative Stress-Induced Apoptosis or Cell-Cycle Arrest , 2007, Cell.

[27]  W. Craigen,et al.  Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death , 2007, Nature Cell Biology.

[28]  Y. Matsuzawa,et al.  Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-α in patients with recent-onset type 1 diabetes , 2007, Diabetologia.

[29]  T. Wadden,et al.  Conference coverage: Selected presentations from the 20th Annual Practical Approaches to the Treatment of Obesity; June 22-24, 2006 , 2006 .

[30]  G. Hajnóczky,et al.  Mitochondrial calcium signalling and cell death: approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis. , 2006, Cell calcium.

[31]  C. Johnston,et al.  Vinegar: medicinal uses and antiglycemic effect. , 2006, MedGenMed : Medscape general medicine.

[32]  Ki-Choon Choi,et al.  Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. , 2005, Endocrinology.

[33]  Nils Welsh,et al.  Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. , 2005, Diabetes.

[34]  J. Krischer,et al.  Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1. , 2005, Diabetes care.

[35]  R. Weissleder,et al.  Imaging inflammation of the pancreatic islets in type 1 diabetes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Teiji Wada,et al.  Mitogen-activated protein kinases in apoptosis regulation , 2004, Oncogene.

[37]  R. Kedzierski,et al.  Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[38]  B. Hilliard,et al.  Transcriptional Regulation of Type I Diabetes by NF-κB 1 , 2003, The Journal of Immunology.

[39]  M. Parmentier,et al.  Functional Characterization of Human Receptors for Short Chain Fatty Acids and Their Role in Polymorphonuclear Cell Activation* , 2003, Journal of Biological Chemistry.

[40]  B. Olde,et al.  Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. , 2003, Biochemical and biophysical research communications.

[41]  S. Dowell,et al.  The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids* , 2003, The Journal of Biological Chemistry.

[42]  R. Tisch,et al.  NF-κB Hyperactivation Has Differential Effects on the APC Function of Nonobese Diabetic Mouse Macrophages1 , 2003, The Journal of Immunology.

[43]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[44]  R. Tisch,et al.  Insulin-Dependent Diabetes Mellitus , 1996, Cell.

[45]  C. Nathan,et al.  Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. , 1994, The Journal of biological chemistry.

[46]  P. Baeuerle,et al.  NF-kappa B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene , 1990, Molecular and cellular biology.

[47]  M. Bohlooly-y,et al.  Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. , 2011, American journal of physiology. Endocrinology and metabolism.

[48]  Y. Obara,et al.  Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. , 2007, Cellular signalling.

[49]  G. Tsujimoto,et al.  Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 , 2005, Nature Medicine.

[50]  R. Schreck.  NF-KBasInducible Transcriptional Activator oftheGranulocyte- Macrophage Colony-Stimulating Factor Gene , 1990 .